Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eunhee Hwang

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Clinical Psychiatry|November 7, 2014
Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trialAnita H Clayton, Karen A Tourian, Kristen Focht, et al.
The Analyst|January 15, 2021
Solid-state colorimetric polydiacetylene liposome biosensor sensitized by gold nanoparticlesJayoung Kim, Byeong-Seok Moon, Eunhee Hwang, et al.
British Journal of Haematology|October 11, 2022
Long-term safety and efficacy of the anti-tissue factor pathway inhibitor marstacimab in participants with severe haemophilia: Phase II study resultsJohnny Mahlangu, Jose Luis Lamas, Juan Cristobal Morales, et al.
International Clinical Psychopharmacology|August 1, 2015
Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysisAnita H Clayton, Eunhee Hwang, Susan G Kornstein, et al.
ACS Nano|August 1, 2012
Dual functions of highly potent graphene derivative-poly-L-lysine composites to inhibit bacteria and support human cellsSurajit Some, Seok-Man Ho, Pooja Dua, et al.
American Journal of Therapeutics|December 23, 2009
The effects of multiple doses of rolofylline on the single-dose pharmacokinetics of midazolam in healthy subjectsMark Stroh, Victor Dishy, Waldemar Radziszewski, et al.
Scientific Reports|September 11, 2014
Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivativesSurajit Some, A-Ryeong Gwon, Eunhee Hwang, et al.
Therapeutic Advances in Hematology|May 8, 2026
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS StudyDavide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Blood|July 3, 2025
Marstacimab Prophylaxis in Hemophilia A/B Without Inhibitors: Results from the Phase 3 BASIS TrialDavide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Clinical Psychiatry|November 7, 2014
Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trialAnita H Clayton, Karen A Tourian, Kristen Focht, et al.
The Analyst|January 15, 2021
Solid-state colorimetric polydiacetylene liposome biosensor sensitized by gold nanoparticlesJayoung Kim, Byeong-Seok Moon, Eunhee Hwang, et al.
British Journal of Haematology|October 11, 2022
Long-term safety and efficacy of the anti-tissue factor pathway inhibitor marstacimab in participants with severe haemophilia: Phase II study resultsJohnny Mahlangu, Jose Luis Lamas, Juan Cristobal Morales, et al.
International Clinical Psychopharmacology|August 1, 2015
Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysisAnita H Clayton, Eunhee Hwang, Susan G Kornstein, et al.
ACS Nano|August 1, 2012
Dual functions of highly potent graphene derivative-poly-L-lysine composites to inhibit bacteria and support human cellsSurajit Some, Seok-Man Ho, Pooja Dua, et al.
American Journal of Therapeutics|December 23, 2009
The effects of multiple doses of rolofylline on the single-dose pharmacokinetics of midazolam in healthy subjectsMark Stroh, Victor Dishy, Waldemar Radziszewski, et al.
Scientific Reports|September 11, 2014
Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivativesSurajit Some, A-Ryeong Gwon, Eunhee Hwang, et al.
Therapeutic Advances in Hematology|May 8, 2026
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS StudyDavide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Blood|July 3, 2025
Marstacimab Prophylaxis in Hemophilia A/B Without Inhibitors: Results from the Phase 3 BASIS TrialDavide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Pageof 4